HER2-Specific DARPin-Liposomes: Fabrication and Characterization

被引:1
|
作者
Guryev, E. L. [1 ]
Antonova, N. O. [1 ]
Yudintsev, A. V. [1 ]
Tretyakov, A. A. [1 ]
Stremovskiy, O. A. [2 ]
Shulga, A. A. [2 ]
Balalaeva, I. V. [1 ]
Deyev, S. M. [1 ,2 ]
Zvyagin, A. V. [1 ]
机构
[1] Lobachevsky State Univ Nizhny Novgorod, Prosp Gagarina 23, Nizhnii Novgorod 603950, Russia
[2] Russian Acad Sci, Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia
来源
BIOLOGICHESKIE MEMBRANY | 2016年 / 33卷 / 03期
关键词
PEGylated DARPin-liposomes; fluorescence; DARPin9-29; HER2; MACROMOLECULAR DRUGS; PHAGE DISPLAY; SOLID TUMORS; CELLS; PROTEINS; IMMUNOLIPOSOMES; NANOMEDICINES; THERAPEUTICS; ACCUMULATION; EXPRESSION;
D O I
10.7868/S023347551603004X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Liposomes based on natural lipids and their analogues are regarded as promising agents for targeted delivery of antitumor drugs. We have created and characterized in vitro DARPin-liposomes specifically interacting with HER2 cancer marker expressed on the surface of many types of cancer cells. The surface of the liposomes was coated with polyethylene glycol to increase the circulation time of the liposomes in the bloodstream and to reduce nonspecific uptake by macrophages. As a targeting agent we used high-affinity nonimmunoglobulin peptide DARPin9-29, specific to HER2 receptor. We anticipate that the created DARPin-liposomes can be used for targeted delivery of anticancer drugs with different mechanisms of action. Besides, the incorporation of fluorescent label rhodamine covalently bound to phospholipids offers the possibility of applying the DARPin-liposomes for diagnostic purposes. We suggest that DARPin-liposomes represent a perspective system for further development and creation of multifunctional liposomal formulations.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 50 条
  • [31] Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET
    Khare, Priyanka
    Sun, Wei
    Ramakrishnan, Sreevidhya
    Hao, Guiyang
    Lo, Su-Tang
    Nham, Kien
    Sun, Xiankai
    Ober, Raimund J.
    Ward, E. Sally
    Swiercz, Rafal
    MABS, 2021, 13 (01)
  • [32] Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
    Helga Bernhard
    Julia Neudorfer
    Kerstin Gebhard
    Heinke Conrad
    Christine Hermann
    Jörg Nährig
    Falko Fend
    Wolfgang Weber
    Dirk H. Busch
    Christian Peschel
    Cancer Immunology, Immunotherapy, 2008, 57 : 271 - 280
  • [33] ADOPTIVE TRANSFER OF HER2-SPECIFIC T CELLS ERADICATES EXPERIMENTAL GLIOBLASTOMA MULTIFORME
    Salsman, V. S.
    Kew, Y.
    Powell, S. Z.
    Wels, W. E.
    Grossman, R.
    Heslop, H. E.
    Gottschalk, S.
    Ahmed, N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 28 - 28
  • [34] Affitoxin-A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors
    Zielinski, Rafal
    Lyakhov, Ilya
    Jacobs, Amy
    Chertov, Oleg
    Kramer-Marek, Gabriela
    Francella, Nicholas
    Stephen, Andrew
    Fisher, Robert
    Blumenthal, Robert
    Capala, Jacek
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (08) : 817 - 825
  • [35] Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
    Hadis Honarvar
    Enrica Calce
    Nunzianna Doti
    Emma Langella
    Anna Orlova
    Jos Buijs
    Valentina D’Amato
    Roberto Bianco
    Michele Saviano
    Vladimir Tolmachev
    Stefania De Luca
    Scientific Reports, 8
  • [36] Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy
    Jeong, Hwa Yeon
    Kim, Hyeri
    Lee, Myunghwa
    Hong, Jinju
    Lee, Joo Han
    Kim, Jeonghyeon
    Choi, Moon Jung
    Park, Yong Serk
    Kim, Sung-Chun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 13
  • [37] Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
    Bernhard, Helga
    Neudorfer, Julia
    Gebhard, Kerstin
    Conrad, Heinke
    Hermann, Christine
    Naehrig, Joerg
    Fend, Falko
    Weber, Wolfgang
    Busch, Dirk H.
    Peschel, Christian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (02) : 271 - 280
  • [38] A novel HER2-specific sensor based on DARPin_9-29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer
    Shramova, E. I.
    Frolova, A. Yu.
    Serova, E. V.
    Deyev, S. M.
    Proshkina, G. M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 734
  • [39] T cells expressing a HER2-specific chimeric antigen receptor as treatment for breast cancer
    Xinshan Xie
    Xiaobin Li
    Gang Liu
    Hui Zhao
    Zhenlong Zhou
    Sheng Xiong
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 11561 - 11570
  • [40] Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule
    Tolmachev, Vladimir
    Orlova, Anna
    Pehrson, Rikard
    Galli, Joakim
    Baastrup, Barbro
    Andersson, Karl
    Sandstrom, Mattias
    Rosik, Daniel
    Carlsson, Jorgen
    Lundqvist, Hans
    Wennborg, Anders
    Nilsson, Fredrik Y.
    CANCER RESEARCH, 2007, 67 (06) : 2773 - 2782